Similarly, serum HMGB1 levels did not differ among individuals with or without resolution of NASH (P = 0.19) irrespective of treatment assignment (Fig 2, bottom panel). The gene discussed is HMGB1; the disease is metabolic dysfunction-associated steatohepatitis.